Skip to content
Continuous Alternating Therapies: A Clinical Perspective episode artwork

Aug 10, 2019 21 min

Continuous Alternating Therapies: A Clinical Perspective

from eCysticFibrosis Review

Inhaled antibiotics have become the foundation of treating chronic respiratory tract Pseudomonas infection in individuals with cystic fibrosis. But what happens when inhaled monotherapy doesn’t sufficiently manage the symptoms? Which patients are appropriate candidates for treatment with multiple inhaled agents? Which medications are appropriate for continuous alternating therapy (CAT)? In this Issue, Dr. Elliott Dasenbrook from the Cleveland Clinic brings the evidence he analyzed in his recent eCysticFibrosis Review Newsletter issue (Vol 8; Issue 10) into the clinic to help guide clinical decision-making. Take our post-test to claim CME credits. To read a companion newsletter click here.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Continuous Alternating Therapies: A Clinical Perspective

0:00 21:26

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of eCysticFibrosis Review?

This episode is 21 minutes long.

When was this eCysticFibrosis Review episode published?

This episode was published on August 10, 2019.

Can I download this eCysticFibrosis Review episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.